Literature DB >> 22398230

Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia®).

Sherea M Stricklin1, William V Stoecker, Ryan K Rader, Antoinette F Hood, Jerome Z Litt, Thomas P Schuman.   

Abstract

Photosensitivity to sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is reported. No previous reports of photosensitivity to any DPP-4 inhibitors are known. Physical examination of the patient revealed edematous plaques confined to sun-exposed areas of the skin. An unusual finding in this case was the spongy sensation upon palpation of the plaques. Histopathology revealed parakeratosis and abundant eosinophils, supporting the clinical impression of cutaneous drug sensitivity. The eruption finally cleared, approximately two years after onset.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22398230

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  2 in total

1.  Fixed drug eruption to sitagliptin.

Authors:  Mrinal Gupta; Anish Gupta
Journal:  J Diabetes Metab Disord       Date:  2015-03-25

2.  Drug-induced generalized skin eruption in a diabetes mellitus patient receiving a dipeptidyl peptidase-4 inhibitor plus metformin.

Authors:  Kaori Nakatani; Takeshi Kurose; Takanori Hyo; Koin Watanabe; Daisuke Yabe; Terue Kawamoto; Yutaka Seino
Journal:  Diabetes Ther       Date:  2012-11-06       Impact factor: 2.945

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.